EVALUATION OF RESULTS OF SIMULTANEOUS MYOMECTOMY AND CESAREAN SECTION
https://doi.org/10.24060/2076-3093-2018-8-1-45-51
Abstract
Introduction. Myoma of the uterus is the most common neoplasm of the female reproductive system. The frequency of combination of uterine fibroids and pregnancy varies from 1.6% to 10.7%, often fibroids occur in pregnant women of late reproductive age. Traditionally, myomectomy during caesarean section was not recommended because of the risk of bleeding and postoperative complications. To assess the safety and feasibility of a one-stage myomectomy in a caesarean section, this study was conducted.
Materials and methods. From 2010 to 2015, we examined 260 pregnant women with uterine myoma, who had a cesarean section with a single-stage myomectomy. The data obtained during the survey were compared with the data of 96 women from the control group. We study assessment of intraoperative blood loss, pre- and postoperative hemoglobin levels, duration of hospitalization.
Results. Statistically significant differences in intraoperative blood loss, changes in hemoglobin levels and in the duration of hospitalization between the examined groups of women were not revealed. A prognostic model has been developed to assess risk factors for intraoperative blood loss of more than 1000 ml.
Conclusion. The size, localization of myomatous nodes are not risk factors for high blood loss in abdominal delivery with a one-stage myomectomy. The factor of risk of hemorrhage is multiple uterine fibroids, whereas the size of myomatous nodes less than 5 cm can be regarded as a protective factor for blood loss. The study showed that a one-stage myomectomy with a caesarean section is safe and can be performed with the surgeon’s experience.
About the Authors
A. G. Yaschuk
Bashkir State Medical University
Russian Federation
Russian Federation
Doctor of Medical Sciences, Professor, Head of the Department of Obstetrics and Gynecology № 2,
3 Lenin str., Ufa, 450008
L. A. Dautova
Bashkir State Medical University
Russian Federation
Russian Federation
Candidate of Medical Sciences, Associate professor at the Department of Obstetrics and Gynecology № 2,
3 Lenin str., Ufa, 450008
A. A. Tyurina
Bashkir State Medical University
Russian Federation
Russian Federation
Post-graduate student at the Department of Obstetrics and Gynecology № 2,
3 Lenin str., Ufa, 450008
A. G. Imelbaeva
Bashkir State Medical University
Russian Federation
Russian Federation
Assistant lecturer at the Department of Obstetrics and Gynecology № 2,
3 Lenin str., Ufa, 450008
References
1. Ezzetdine D., Norwitz E. Are women with uterine fibroids at increased risk for adverse pregnancy outcome? Clin Obstet Gynecol. 2016;59(1):119–27. DOI: 10.1097/GRF.0000000000000169
2. Sidorova I.S., Unanyan A.L., Ageev M.B., Vedernikova N.V., Zholobova M.N. Current status of the pathogenesis, clinical features, diagnosis, and treatment. Akusherstvo, Ginekologiya i Reproduktsiya = Obstetrics, Gynecology, and Reproduction. 2012;6(4):22–8. (in Russ.)
3. Buianova S.N., Iudina N.V., Gukasian S.A., Mgeliashvili M.V. Uterine myoma growth: current aspects. Rossiyskiy vestnik akushera-ginekologa = Russian Bulletin of Obstetrician-Gynecologist. 2012;12(4):42–8. (in Russ.)
4. Nakai G., Yamada T., Hamada T., Atsukawa N., Tanaka Y., Yamamoto K., et al. Pathological findings of uterine tumors preoperatively diagnosed as red degeneration of leiomyoma by MRI. Abdom Radiol. 2017;42(7):1825–31. DOI: 10.1007/s00261-017-1126-3
5. Zhang Y., Hua K. Patients’ age, myoma size, myoma location, and interval between myomectomy and pregnancy may influence the pregnancy rate and live birth rate after myomectomy. J Laparoendosc Adv Surg Tech. 2014;24(2):95–9. DOI: 10.1089/lap.2013.0490
6. Mas A., Tarazona M., Dasí Carrasco J., Estaca G., Cristóbal I., Monleón J. Updated approaches for management of uterine fibroids. Int J Womens Health. 2017;(9):607–17. DOI: 10.2147/IJWH.S138982
7. Levy G., Hill M., Beall S., Zarek S., Segars J., Catherino W. Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances. J Assist Reprod Genet. 2012;29(8):703–12. DOI: 10.1007/s10815-012- 9784-0
8. Sparić R., Kadija S., Stefanović A., Spremović Radjenović S., Likić Ladjević I., Popović J., Tinelli A. Cesarean myomectomy in modern obstetrics: more light and fewer shadows. J Obstet Gynaecol Res. 2017;43(5):798–804. PMID 28168805
9. Song D., Zhang W., Chames M.C., Guo J. Myomectomy during cesarean delivery. Int J Gynecol Obstet. 2013;121(3):208–13. DOI:10.1016/j. ijgo.2013.01.021
10. Akbas M., Mihmanli V., Bulut B., Temel Yuksel I., Karahisar G., Demirayak G. Myomectomy for intramural fibroids during caesarean section: a therapeutic dilemma. J Obstet Gynaecol. 2016;37(2):141–5. DOI: 10.1080/01443615.2016.1229272
11. Wise L., Laughlin-Tommaso S. Epidemiology of uterine fibroids: from menarche to menopause. Clin Obstet Gynecol. 2016;59(1):2–24. DOI: 10.1097/GRF.0000000000000164
12. Wang H., Tian Y., Xue Z., Zhang Y., Dai Y. Associations between uterine fibroids and obstetric outcomes in twin pregnancies. Int J Gynecol Obstet. 2016;135(1):22–7. DOI: 10.1016/j.ijgo.2016.04.013
13. Pergialiotis V., Sinanidis I., Louloudis I., Vichos T., Perrea D., Doumouchtsis S. Perioperative complications of cesarean delivery myomectomy. Obstet Gynecol. 2017;130(6):1295–303. DOI: 10.1097/AOG.0000000000002342
14. Song D., Zhang W., Chames M., Guo J. Myomectomy during cesarean delivery. Int J Gynecol Obstet. 2013;121(3):208–13. DOI: 10.1016/j.ijgo.2013.01.021
15. Topçu H., İskender C., Timur H., Kaymak O., Memur T., Danışman N. Outcomes after cesarean myomectomy versus cesarean alone among pregnant women with uterine leiomyomas. Int J Gynecol Obstet. 2015;130(3):244–6. DOI: 10.1016/j.ijgo.2015.03.035
16. Dedes I., Schäffer L., Zimmermann R., Burkhardt T., Haslinger C. Outcome and risk factors of cesarean delivery with and without cesarean myomectomy in women with uterine myomatas. Arch Gynecol Obstet. 2016;295(1):27–32. DOI: 10.1007/s00404-016-4177-8
17. Tinelli A., Malvasi A., Mynbaev O.A., Barbera A., Perrone E., Guido M., et al. The surgical outcome of intracapsular cesarean myomectomy. A match control study. J Matern Fetal Neonatal Med. 2014;27(1):66–71. DOI: 10.3109/14767058.2013.804052
18. Parazzini F., Tozzi L., Bianchi S. Pregnancy outcome and uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016;34:74–84. DOI: 10.1016/j.bpobgyn.2015.11.017
19. Senturk M., Polat M., Doğan O., Pulatoğlu Ç., Yardımcı O., Karakuş R., et al. Outcome of cesarean myomectomy: is it a safe procedure? Geburtshilfe Frauenheilkunde. 2017;77(11):1200–06. DOI: 10.1055/s0043-120918
20. Kathpalia S., Arora D., Vasudeva S., Singh S. Myomectomy at cesarean section: a safe option. Med J Armed Forces India. 2016;72:S161–3. DOI: 10.1016/j.mjafi.2016.03.006
Review
For citations:
Yaschuk A.G., Dautova L.A., Tyurina A.A., Imelbaeva A.G. EVALUATION OF RESULTS OF SIMULTANEOUS MYOMECTOMY AND CESAREAN SECTION. Creative surgery and oncology. 2018;8(1):45-51. (In Russ.) https://doi.org/10.24060/2076-3093-2018-8-1-45-51
Views:
2769
Email this article 